Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia

NCT00148083 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT00148083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Lead sponsor
University of Illinois at Chicago
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
March 31, 2006
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia